Shift to Everolimus (RAD) Kidney Sparing Study

NCT00420537 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

34

Enrollment

OTHER

Sponsor class

Stopped A cluster of adverse events in everolimus arm was noted.

Conditions

Kidney Dysfunction
Heart Transplantation

Interventions

DRUG: cyclosporine
DRUG: cyclosporine
DRUG: Mycophenolate mofetil
DRUG: Everolimus

Sponsor

University of Bologna